This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, US Government as Represented by the Secretary of the Army. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Ayumu Taguchi: Innovator in Lung Cancer Detection and Treatment
Introduction
Ayumu Taguchi is a prominent inventor based in Houston, Texas, known for his significant contributions to the field of medical technology. He has developed innovative methods aimed at the early detection and treatment of lung cancer, a disease that affects millions worldwide. His work is crucial in improving patient outcomes through timely diagnosis and intervention.
Latest Patents
Ayumu Taguchi holds 1 patent for his groundbreaking invention titled "Methods for the detection and treatment of lung cancer." This patent provides methods and related kits designed for the early detection of lung cancer and the assessment of the risk of harboring the disease. His innovative approach has the potential to revolutionize how lung cancer is diagnosed and treated.
Career Highlights
Taguchi is affiliated with the University of Texas System, where he continues to advance his research and development efforts. His work is characterized by a commitment to enhancing medical technologies that can lead to better health outcomes for patients suffering from lung cancer.
Collaborations
Throughout his career, Ayumu Taguchi has collaborated with esteemed colleagues, including Samir Hanash and Ziding Feng. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.
Conclusion
Ayumu Taguchi's contributions to lung cancer detection and treatment exemplify the impact of innovative thinking in the medical field. His dedication to improving patient care through technology is commendable and highlights the importance of continued research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile